Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33) | RFA AT 16 005

Opportunity Information: Apply for RFA AT 16 005

The Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33) is a National Institutes of Health (NIH) grant opportunity from the National Center for Complementary and Integrative Health (NCCIH) designed to move mind and body intervention research beyond simple "does it work" questions and toward a clear, testable understanding of how these approaches work. The core idea is to fund projects that can identify the biological, neurological, physiological, and/or behavioral mechanisms that drive outcomes in mind and body interventions, and then use that mechanistic knowledge to deliberately optimize or strengthen the intervention so it more reliably modulates the target mechanism and produces meaningful benefits.

This funding announcement uses a two-phase, milestone-driven structure. The first phase (R61) supports early, innovative mechanistic work aimed at uncovering and characterizing the underlying processes relevant to a mind and body intervention. The interventions of interest include approaches such as meditation, spinal manipulation, massage, yoga, tai chi, hypnosis, and acupuncture, among other mind-body modalities. In this initial phase, applicants are expected to do more than describe correlations; they are encouraged to design studies that can credibly probe causality or at least provide strong evidence that a specific mechanism or process is central to how the intervention produces effects. Mechanisms may include neural circuit activity, autonomic or endocrine regulation, immune or inflammatory pathways, pain modulation systems, sensorimotor integration, cognitive and affective processes, stress reactivity, or other measurable pathways that plausibly connect the intervention to outcomes.

The second phase (R33) is intended to build directly on what is learned in the R61 phase. The goal here is to use the mechanistic findings to improve, refine, enhance, or otherwise optimize the intervention so that it more effectively engages the identified mechanism or process. This can happen through rigorous intervention validation and refinement (for example, adjusting dosing, delivery format, fidelity monitoring, tailoring components, or identifying the active ingredients), or through combined approaches where multiple components are deliberately integrated to modulate the same underlying mechanism more strongly than any single component alone. Importantly, the second phase is also expected to produce preliminary evidence linking mechanistic modulation to something that matters clinically or functionally, such as symptom reduction, improved function, better quality of life, or another measurable benefit for a defined condition or disorder. In other words, the project should not stop at showing the mechanism shifts; it should begin to connect that mechanistic shift to a meaningful outcome in a specific health context.

In practical terms, this FOA is oriented toward a translation-minded pathway: identify a mechanism, demonstrate that the intervention affects it, and then intentionally tune the intervention to produce a stronger, more consistent mechanistic effect that is plausibly responsible for improved outcomes. The phased structure is meant to reduce the risk of investing heavily in large studies before the field has nailed down what the intervention is actually doing and how best to deliver it to achieve reliable benefits.

The opportunity is categorized as a discretionary grant in the health area (CFDA 93.213) and was released under Funding Opportunity Number RFA-AT-16-005. It is open to a wide range of applicant organizations, including state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and eligible tribal governments and tribal organizations. The announcement also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

There are strict restrictions regarding foreign involvement. Non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed. The original closing date listed for this opportunity was January 15, 2016, and the FOA creation date was September 25, 2015.

Overall, this R61/R33 mechanism is geared toward researchers who can propose a coherent mechanistic storyline with clear measurements, credible methods for testing or interrogating that mechanism, and a realistic plan for using early mechanistic results to optimize an intervention in a second phase. The emphasis is on producing actionable mechanistic knowledge that can sharpen mind and body interventions into more targeted, testable, and clinically meaningful tools for specific conditions, rather than treating these interventions as broad, hard-to-define packages whose effects are difficult to explain or replicate.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
• This funding opportunity was created on 2015-09-25.
• Applicants must submit their applications by 2016-01-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AT 16 005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: